PPAR-Î³ Modulators as Current and Potential Cancer Treatments.

Chi, Tiange; Wang, Mina; Wang, Xu; Yang, Ke; Xie, Feiyu; Liao, Zehuan; Wei, Peng

Chi, Tiange; Wang, Mina; Wang, Xu; Yang, Ke; Xie, Feiyu; Liao, Zehuan; Wei, Peng.

Afiliación

Chi T; School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China.
Wang M; First Clinical Medical School, Beijing University of Chinese Medicine, Beijing, China.
Wang X; School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China.
Yang K; Department of Acupuncture and Moxibustion, Beijing Key Laboratory of Acupuncture Neuromodulation, Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing, China.
Xie F; School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China.
Liao Z; School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China.
Wei P; School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China.

Front Oncol ; 11: 737776, 2021.

Article en En | MEDLINE | ID: mdl-34631571

Palabras clave

PPAR-Î³; PPAR-Î³ agonists; PPAR-Î³ antagonists; PPAR-Î³ modulators; cancer treatment

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Front Oncol Año: 2021 Tipo del documento: Article País de afiliación: China Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google